Tissue Engineering at the University of Sheffield uses a patient's own cells to grow restorative tissue. This autologous approach overcomes both the shortage of donor organs and the complexities of matching translogous tissue. The objective is to meet clinical needs through the production of tissue engineered medical products (TEMPs) and to prove these in clinical trials.
